PHOTO
- Future expansion includes upcoming 100 bed hospital in Dubai Hills
Dubai: King’s College Hospital London in the UAE (KCH) officially opened the doors of its Marina Medical Centre this morning, the first facility with British NHS standards to be located in Dubai Marina. Alongside the new home for KCH, the newly appointed CEO, Christian Schuhmacher, announced KCH’s plans on providing international standards of care and focussing on primary healthcare as frontline care.
The centre was inaugurated by His Excellency Humaid Al Qutami, Director-General of the Dubai Health Authority and H.E. Ahmed H. Al Tayer, Chairman of King’s College Hospital London in the UAE in presence of high-level officials.
Al Qutami highlighted that the growth of the healthcare sector in Dubai is driven by a population rise and an increase in private health infrastructure.
He congratulated the management at KCH and highlighted that Dubai is an attractive location for health investment.
Al Qutami said that investment in the private health sector has witnessed sustained growth and that DHA recently launched a health investment strategy 2017-2020, with an aim to promote Dubai as a viable and competitive hub for need-based investment in healthcare. The strategy aims to guide and support investors to build sustainable public-private partnership models in healthcare in Dubai.
Al Qutami said that the DHA is keen to support private sector investment and such reputed healthcare providers with decades of experience and expertise in the medical sector, which help provide the population in Dubai with high-quality health services.
Christian Schuhmacher brings with him over 18 years’ experience in hospital governance, public affairs and business development, four years based locally and a further 14 years internationally. Speaking at the Marina Medical Centre opening ceremony, Schuhmacher stated, “The culture of King’s is to provide the best of British healthcare by complying to UK evidence-based care. Our utilisation results over the past year of other KCH facilities in the UAE not only demonstrate KCH’s unwavering commitment to healthcare in the UAE but also show the real progress we are making in delivering evidence-based healthcare. We constantly strive to provide the most cost-effective and healthiest treatment options for our patients.”
The findings from the one-year review of other KCH facilities in Dubai showed that a Family Medicine Consultant rather than a Specialist treated 30 per cent of patients at KCH in the UAE. “This is in line with our concept of primary care being the first line of treatment,” said Schuhmacher “We are fervent advocates of evidence-based healthcare, and are proud to bring this ethos of care to the community in Dubai Marina.”
H.E. Ahmed H. Al Tayer, Chairman of King’s College Hospital London in the UAE added, “By bringing in this new Centre to Dubai Marina, we are one step closer to helping the UAE achieve a world-class healthcare system. This is just the start for KCH as we continue our expansion with our upcoming 100-bed hospital in Dubai Hills that will provide integrated pathways into King’s in London. For example, clinical services like Foetal Medicine will draw on experience from the Institute of Foetal Medicine in London.”
Other senior members that were present at the inauguration included Mr. Ian Smith, Chairman of King’s College Hospital London (NHS Trust); and Mr. Mohammed Al Raqbani, General Manager of Dubai Investments Industries.
The new facility, located in The Residences at Marina Gate I, in the heart of Dubai Marina, brings KCH’s UAE footprint to a total of three Medical Centres; the first being the flagship clinic in Abu Dhabi, and the one-year-old Medical Centre in Jumeirah. The Marina Medical Centre specialises in Family Medicine, Paediatrics, Paediatric Allergy, Paediatric Hepatology, Obstetrics and Gynaecology, Foetal Medicine, Plastic Surgery, ENT as well as Dentistry, and will feed alongside the other clinics into the upcoming hospital, set to open in January 2019. All KCH medical centres are fully integrated 365 days a year with King’s College Hospital in London.
-Ends-
Media contact: Alia Karim, Hill+Knowlton Strategies: 0565019503 or Alia.Karim@hkstrategies.com
About King’s College Hospital London in the United Arab Emirates
The world-renowned British teaching hospital King’s College Hospital London, is now providing trusted patient care in the UAE after a joint venture with Al Tayer Group, Dubai Investments and UK-based Ashmore Group. King’s College Hospital London has three operational Medical Centres in the UAE; one in Abu Dhabi which has been operational since 2014, one in Jumeirah that opened in September 2017, and the latest in Dubai Marina that was inaugurated in September 2018. This will be closely followed by the 100-bed King’s College Hospital London expected to open in January 2019 in Dubai Hills. The hospital will focus on a variety of specialties including: Orthopaedics and Neurospinal; Cardiology including Interventional Cardiology; General Surgery, Metabolic Surgery, ENT, and Plastic Surgery; Obstetrics and Gynaecology; and others such as, Gastroenterology, Hepatology, Endocrinology, Paediatrics, Urology and Pain management. For more information or to book an appointment please call +971 2 501 4000 (Abu Dhabi), +971 4 378 9555 (JMC, Dubai), 04 581 3222 (MMC, Dubai) or visit www.kch.ae
About King’s College Hospital, London: King’s College Hospital NHS Foundation Trust is one of the UK’s largest and busiest teaching hospitals, with over 10,500 staff and providing over 1m patient contacts every year. 9,000 babies are delivered by our hospitals each year, and over 750 patients come to our Emergency Departments every day. The hospital also trains over 900 dentists, 750 doctors and 300 nurses every year and is part of Kings Academic Partnership, leading on clinical research and academic excellence across a range of disciplines. The Trust is recognised in the UK for its leading position across a full range of capabilities and is also recognised internationally for its work in liver disease and transplantation (Europe’s largest liver transplantation centre), neurosciences, cardiac, haemato-oncology, stroke and major trauma. For more information, please visit http://www.kch.nhs.uk/
About Ashmore Group plc: Ashmore is a specialist Emerging Markets asset manager with assets under management of US$51.1 billion (as at 30 September 2015) invested across a number of Emerging Markets investment themes including external debt, local currency, corporate debt, blended debt, equity, alternatives (special situations, healthcare, infrastructure and real estate), overlay / liquidity and multi-asset products. The business was founded in 1992 as part of the Australia and New Zealand Banking Group. It became independent in 1999 and listed on the London Stock Exchange in 2006. Ashmore Group plc (ASHM:LN) is a member of the FTSE 250 index. The company has significant employee ownership. Ashmore is headquartered in London, England and has offices in China, Colombia, India, Indonesia, Japan, Saudi Arabia, Singapore, Turkey, the United Arab Emirates and the United States. Website: www.ashmoregroup.com
About Al Tayer Group: Al Tayer Group is a diversified regional business established in 1979 with its headquarters in Dubai, UAE. Since its inception, the Group has grown rapidly and currently operates in 12 countries in the Middle-East and beyond, with over 9,000 employees. It has built leading operations in multiple sectors, including automotive, contracting, retail, real estate and services.
Al Tayer Group operates leading, quality-focused businesses in automobile sales and service, luxury and lifestyle retail, perfumes and cosmetics distribution, real estate, engineering as well as interiors contracting. The Group’s portfolio includes several of the world’s leading brands such as Armani, Bvlgari, Banana Republic, Ford, Ferrari, Gucci, Gap, Harvey Nichols and Maserati. The Group operates over 200 stores across multiple markets in the Middle East. In addition, Al Tayer Group has investments in contracting, supply chain management, precision tools manufacturing and travel agency services.
The Group’s value system is committed to excellence in delivering quality and customer service by empowering employees, celebrating diversity and encouraging thought leadership, within an ethics-driven corporate culture. The Group supports various charitable and is involved patron of many initiatives which grant children access to quality education and future opportunities. For more information on Al Tayer Group, please visit www.altayer.com.
About Dubai Investments PJSC: Dubai Investments PJSC is a leading investment company listed on the Dubai Financial Market with over 19,800 shareholders and a paid-up capital of AED 4 billion. Incorporated in 1995, the company has grown exponentially with investments in a number of businesses across three core sectors – real estate, manufacturing & industrial and financial investments.Since its inception, Dubai Investments has
challenged the norms and introduced cutting-edge technologies, pioneering business models, unique investment strategies and innovative concepts across its diversified portfolio spanning different sectors and markets across the globe.
Dubai Investments currently has over 40 subsidiaries & joint ventures under its portfolio, across a wide array of industries and continues to seek new investment opportunities in new sectors, locally and internationally, as part of its strategic expansion plans.
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
